Vocal.

"A cure is within sight": Talking to Janssen’s Jane Griffiths about Cancer

Met with Jane Griffiths, Ph.D., Company Group Chairman, Europe, Middle East and Africa, for Janssen on the state of affairs in oncology.

New Survey: This is top of mind for Market Access leaders today

Wonder what moves US Market Access? Here's my recent survey with 66 industry executives on the big item topics.

5 insights from the largest-ever patient centricity survey in industry

Time for an update on our working group, ‘The Aurora Project’ and our global patient-centricity survey with 2,346 responses.

Making it Personal: Paul Perreault's lessons for Big Pharma

Talking to CSL CEO Paul Perreault about the need for pharma to better connect with patients, drug pricing and CSL lessons for big pharma.

Christi Shaw: 'Go Long on Value'

I recently met with U.S. President of Novartis , for a free-ranging chat about trust in pharma, patient input and driving value.

Can clinical trials ever be patient-centred?

In September I met with over a dozen clinical leaders to discuss evolving roles of patients in clinical trials. Can we set a new paradigm?

The state of play in RWE, big data, HEOR and value-based interventions.

A summary of a unique gathering of thought leaders to discuss the state of real world evidence, big data, HEOR and value-based interventions

Empowering Patients: A Roadmap for Change

Putting patient views and values at the heart of clinical research is key to a healthcare revolution. Here's an early roadmap for change.

10 Takeaways from the Leading Industry RWD Collaboration

With the shift from volume to value in the healthcare marketplace, we witness significant changes in the payment model coupled with moves...

Homegrown Jihadi Terrorism – Examining the new 'Threat from Within'

"Homegrown Jihadi Terrorism – Examining the new 'Threat from Within' (2010)", München: AVM, ISBN: 978-3-89975-371-4, Paperback 68 pp.

Help Ukraine